文献速递神经肿瘤

岩斜区脑膜瘤30年多模式治疗长期结局与管理策略

Petroclival meningiomas: long-term outcomes of multimodal treatments and management strategies based on 30 years of experience at a single institution.
PubMed 文献 · J Neurosurg · 2019-05-10

总体无进展生存率5年为85.8%、10年为81.2%;计划性次全切除加辅助放射外科的多模式策略在局部控制与术后生活质量间可行。

要点

  • 后经岩骨入路最常用(44例,48%),其次为单纯乙状窦后入路(30例)。
  • GTR仅13例,非GTR+RS/RT 56例,非GTR未辅助治疗23例。
  • 各亚组进展或复发率分别为7.7%、12.5%、30.4%。

核心结论

  • 计划性不完全切除后辅助放射外科的多模式策略对大型岩斜区脑膜瘤可行,兼顾局部肿瘤控制与术后生活质量。

研究设计与样本

  • 临床随访平均121个月(范围1—368个月),影像随访平均105个月(范围1—348个月)。

主要发现

  • 总体无进展生存率5年为85.8%,10年为81.2%。
  • 后经岩骨入路44例(48%)最常用,单纯乙状窦后入路30例次之。
  • 进展或复发率:GTR仅13例为7.7%,非GTR+RS/RT 56例为12.5%,非GTR仅23例为30.4%。

关键数值与推荐

  • 按初始切除程度与辅助治疗分为三组:GTR仅、非GTR+RS/RT、非GTR仅。
  • GTR仅7.7%,非GTR+RS/RT 12.5%,非GTR仅30.4%(各组进展或复发率)。

临床怎么用

  • 对大型岩斜区脑膜瘤可考虑计划性不完全切除联合术后辅助放射外科以平衡肿瘤控制与生活质量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: A thorough investigation of the long-term outcomes and chronological changes of multimodal treatments for petroclival meningiomas is required to establish optimal management strategies. The authors retrospectively reviewed the long-term clinical outcomes of patients with petroclival meningioma according to various treatments, including various surgical approaches, and they suggest treatment strategies based on 30 years of experience at a single institution. METHODS: Ninety-two patients with petroclival meningiomas were treated surgically at the authors' institution from 1986 to 2015. Patient demographics, overall survival, local tumor control rates, and functional outcomes according to multimodal treatments, as well as chronological change in management strategies, were evaluated. The mean clinical and radiological follow-up periods were 121 months (range 1-368 months) and 105 months (range 1-348 months), respectively. RESULTS: A posterior transpetrosal approach was most frequently selected and was followed in 44 patients (48%); a simple retrosigmoid approach, undertaken in 30 patients, was the second most common. The initial extent of resection and following adjuvant treatment modality were classified into 3 subgroups: gross-total resection (GTR) only in 13 patients; non-GTR treatment followed by adjuvant radiosurgery or radiation therapy (non-GTR+RS/RT) in 56 patients; and non-GTR without adjuvant treatment (non-GTR only) in 23 patients. The overall progression-free survival rate was 85.8% at 5 years and 81.2% at 10 years. Progression or recurrence rates according to each subgroup were 7.7%, 12.5%, and 30.4%, respectively. CONCLUSIONS: The authors' preferred multimodal treatment strategy, that of planned incomplete resection and subsequent adjuvant radiosurgery, is a feasible option for the management of patients with large petroclival meningiomas, considering both local tumor control and postoperative quality of life.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Kim JW, Jung HW, Kim YH, et al. Petroclival meningiomas: long-term outcomes of multimodal treatments and management strategies based on 30 years of experience at a single institution. J Neurosurg. 2019. PMID: 31075775. doi:10.3171/2019.2.JNS182604

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。